Autoantibodies in small lung cell carcinoma patients show cross-reactivity among ZIC1, ZIC2, and ZIC4 proteins [15], suggesting that immunoreactivities of the autoantibodies are directed primarily against the conserved zinc finger domains of ZIC [16]. Here, ZIC4 is linked to small cell lung carcinoma.